Kura Oncology, Inc. (KURA)
NASDAQ: KURA · IEX Real-Time Price · USD
21.76
-0.30 (-1.36%)
Jun 7, 2024, 4:00 PM EDT - Market closed
Kura Oncology Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Kura Oncology stock have an average target of 27.94, with a low estimate of 10.5 and a high estimate of 37. The average target predicts an increase of 28.40% from the current stock price of 21.76.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Kura Oncology stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 4 |
| Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Reiterates $32 | Buy | Reiterates | $32 | +47.06% | May 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +47.06% | May 14, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $32 | Buy | Reiterates | $32 | +47.06% | May 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +47.06% | May 3, 2024 |
| Wedbush | Wedbush | Buy Reiterates $37 | Buy | Reiterates | $37 | +70.04% | May 3, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
14.35M
EPS This Year
-2.58
from -2.08
EPS Next Year
-2.70
from -2.58
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 51.8M | 473.8M | 1.7B | 593.6M |
| Avg | n/a | 14.3M | 138.6M | 370.1M | 388.8M |
| Low | n/a | n/a | 7.6M | 35.7M | 206.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 3,202.2% | 1,103.8% | 60.4% |
| Avg | - | - | 866.3% | 166.9% | 5.1% |
| Low | - | - | -46.7% | -74.3% | -44.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.48 | -2.13 | 1.27 | 8.24 | 1.00 |
| Avg | -2.58 | -2.70 | -2.10 | 0.06 | -0.16 |
| Low | -2.81 | -2.88 | -3.31 | -3.40 | -1.31 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 1,529.9% |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.